Large Cell Lung Carcinoma Recruiting Phase 3 Trials for Nivolumab (DB09035)

Also known as: Carcinoma, Large Cell Lung

IndicationStatusPhase
DBCOND0044133 (Large Cell Lung Carcinoma)Recruiting3
clinicaltrials.gov IdentifierTitlePurposeDrugs